RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

NCT04485195 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Vernakalant
DRUG: Procainamide

Sponsor

Ottawa Hospital Research Institute